Position
Fidelity in Cytokinetics Inc
Back to the book · All holders of CYTK
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $224.5M$31.17 → $65.00
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 36.7M | $847.8M | — | — | — | 0.0% |
| Q1 2026 | 23.3M | $725.1M | $31.17 | $187.6M | −$310.3M | 0.0% |
| Q2 2026 | 6.64M | $431.4M | $65.00 | $224.5M | −$518.2M | 0.0% |